The therapeutic effects and antioxidant properties of epigallocatechin-3 gallate: A new review

[1]  M. Zeng,et al.  EGCG protects against myocardial I/RI by regulating lncRNA Gm4419-mediated epigenetic silencing of the DUSP5/ERK1/2 axis. , 2021, Toxicology and applied pharmacology.

[2]  Y. Zong,et al.  (-)-Epigallocatechin-3-gallate (EGCG) prevents aminoglycosides-induced ototoxicity via anti-oxidative and anti-apoptotic pathways. , 2021, International journal of pediatric otorhinolaryngology.

[3]  Weiren Huang,et al.  EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway , 2020, Frontiers in Cell and Developmental Biology.

[4]  G. M. Soliman,et al.  Epigallocatechin-3-Gallate-Loaded Gold Nanoparticles: Preparation and Evaluation of Anticancer Efficacy in Ehrlich Tumor-Bearing Mice , 2020, Pharmaceuticals.

[5]  Y. Naito,et al.  Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids , 2020, Journal of clinical biochemistry and nutrition.

[6]  Yuhua Chen,et al.  EGCG protects vascular endothelial cells from oxidative stress-induced damage by targeting the autophagy-dependent PI3K-AKT-mTOR pathway , 2020, Annals of translational medicine.

[7]  Jinke Lin,et al.  Chemoprevention of elite tea variety CFT‐1 rich in EGCG against chemically induced liver cancer in rats , 2019, Food science & nutrition.

[8]  Marwa Hassan,et al.  The protective effect of epigallocatechin-3-gallate on testicular oxidative stress in lead-induced toxicity mediated by Cyp19 gene / estradiol level. , 2019, Toxicology.

[9]  B. Pang,et al.  Epigallocatechin-3-gallate inhibits proliferation and induces apoptosis in odontogenic keratocyst keratinocytes. , 2019, Oral diseases.

[10]  A. Mahmoud,et al.  Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  H. Tanabe,et al.  Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases , 2018, Molecules.

[12]  J. Regenstein,et al.  Antioxidant and Antimicrobial Activities of (-)-Epigallocatechin-3-gallate (EGCG) and its Potential to Preserve the Quality and Safety of Foods. , 2018, Comprehensive reviews in food science and food safety.

[13]  Hong Wang,et al.  Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice , 2018, Molecular nutrition & food research.

[14]  P. Thanikachalam,et al.  Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases. , 2018, Journal of ethnopharmacology.

[15]  Kumar Ganesan,et al.  Polyphenol-Rich Lentils and Their Health Promoting Effects , 2017, International journal of molecular sciences.

[16]  N. Yamamoto,et al.  Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways , 2017, Neuroscience.

[17]  M. Abukhalil,et al.  Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Y. Man,et al.  Green Tea Extracts Epigallocatechin-3-gallate for Different Treatments , 2017, BioMed research international.

[19]  Sahar S. Abd El-Rahman,et al.  Epigallocatechin‐3‐Gallate: The Prospective Targeting of Cancer Stem Cells and Preventing Metastasis of Chemically‐Induced Mammary Cancer in Rats , 2017, The American journal of the medical sciences.

[20]  J. Pandey,et al.  Effect of Green Tea Polyphenol Epigallocatechin-3-gallate on the Aggregation of αA(66-80) Peptide, a Major Fragment of αA-crystallin Involved in Cataract Development , 2017, Current eye research.

[21]  Haichao Wang,et al.  Involvement of PKCα and ERK1/2 signaling pathways in EGCG’s protection against stress-induced neural injuries in Wistar rats , 2017, Neuroscience.

[22]  Weiren Huang,et al.  EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9. , 2017, The Journal of nutritional biochemistry.

[23]  Y. Mi,et al.  Effect of epigallocatechin-3-gallate on acrylamide-induced oxidative stress and apoptosis in PC12 cells , 2017, Human & experimental toxicology.

[24]  J. Oyama,et al.  EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice. , 2017, Journal of cardiology.

[25]  K. Chopra,et al.  Better Management of Alcohol Liver Disease Using a ‘Microstructured Synbox’ System Comprising L. plantarum and EGCG , 2017, PloS one.

[26]  H. Qutub,et al.  Epigallocatechin-3-gallate counters cisplatin toxicity of rat testes , 2017, Pharmaceutical biology.

[27]  A. Yalçın,et al.  Kurkumin, Kuersetin ve Çay Kateşinlerinin Anti-Kanser Etkileri , 2016 .

[28]  K. Chang,et al.  Nitric oxide pathway activity modulation alters the protective effects of (−)Epigallocatechin-3-gallate on reserpine-induced impairment in rats , 2016, Behavioural Brain Research.

[29]  F. Mohr,et al.  Epigallocatechin gallate attenuates cardiopulmonary bypass-associated lung injury. , 2016, The Journal of surgical research.

[30]  Neha Singh,et al.  Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG) , 2015, Nutrition Journal.

[31]  Bian-hua Zhou,et al.  Fluoride-induced oxidative stress is involved in the morphological damage and dysfunction of liver in female mice. , 2015, Chemosphere.

[32]  A. Risco,et al.  Implication of Akt, ERK1/2 and alternative p38MAPK signalling pathways in human colon cancer cell apoptosis induced by green tea EGCG. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[33]  T. Lai,et al.  Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma , 2015, Neuroscience Letters.

[34]  S. Faure,et al.  Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome , 2015, Nutrients.

[35]  E. El-demerdash,et al.  Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study. , 2015, Biochemical pharmacology.

[36]  Li Jiang,et al.  Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice. , 2014, Acta histochemica.

[37]  M. le Gall,et al.  Green tea decoction improves glucose tolerance and reduces weight gain of rats fed normal and high-fat diet. , 2014, The Journal of nutritional biochemistry.

[38]  C. Pichard,et al.  Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. , 2013, Clinical nutrition.

[39]  Hyeonseok Ko,et al.  TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells. , 2013, Cancer Letters.

[40]  P. Kalaiselvi,et al.  Impact of epigallo catechin-3-gallate on acetylcholine-acetylcholine esterase cycle in aged rat brain , 2012, Neurochemistry International.

[41]  C. Gottfried,et al.  Epigallocatechin-3-gallate protects rat brain mitochondria against cadmium-induced damage. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[42]  D. Rakheja,et al.  The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis. , 2011, Kidney international.

[43]  A. Nanji,et al.  Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. , 2010, Toxicology.

[44]  T. Nakagawa,et al.  (–)‐Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor–vascular endothelial growth factor receptor axis , 2009, Cancer science.

[45]  B. Falsini,et al.  Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: A short-term study by pattern electroretinogram , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[46]  J. Donovan,et al.  Short‐term administration of (‐)‐epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice , 2005 .

[47]  S. Suh,et al.  Protective effect of green tea polyphenol (‐)‐epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates , 2003, Phytotherapy research : PTR.

[48]  X. Wan,et al.  The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperuricemic mice. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[49]  R. Wu,et al.  Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells. , 2017, Biochemical and biophysical research communications.

[50]  R. Keck,et al.  Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model. , 2014, International journal of oncology.

[51]  S. Shankar,et al.  EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin , 2012, Molecular and Cellular Biochemistry.